Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.
Graziani G, Tentori L, Navarra P. Graziani G, et al. Among authors: tentori l. Pharmacol Res. 2012 Jan;65(1):9-22. doi: 10.1016/j.phrs.2011.09.002. Epub 2011 Sep 10. Pharmacol Res. 2012. PMID: 21930211 Review.
IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro.
Tentori L, Leonetti C, Lanzilli G, Bonmassar E. Tentori L, et al. Int J Immunopharmacol. 1990;12(8):831-40. doi: 10.1016/0192-0561(90)90002-5. Int J Immunopharmacol. 1990. PMID: 2292462
Temozolomide reduces the metastatic potential of Lewis lung carcinoma (3LL) in mice: role of alpha-6 integrin phosphorylation.
Tentori L, Leonetti C, Aquino A. Tentori L, et al. Eur J Cancer. 1995;31A(5):746-54. doi: 10.1016/0959-8049(94)00521-6. Eur J Cancer. 1995. PMID: 7640049
Effects of diheptyldiselenide (DDS) on human tumor cell lines and on peripheral blood mononuclear cells.
Tentori L, Prete SP, Pepponi R. Tentori L, et al. J Chemother. 1993 Oct;5(5):325-33. doi: 10.1080/1120009x.1993.11741078. J Chemother. 1993. PMID: 8106907
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).
Tentori L, Leonetti C, Lozupone F, Bonmassar E. Tentori L, et al. Cancer Immunol Immunother. 1995 Dec;41(6):375-83. doi: 10.1007/BF01526557. Cancer Immunol Immunother. 1995. PMID: 8635195
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine.
Giuliani A, Tentori L, Pepponi R, Porcelli SA, Aquino A, Orlando L, Sugita M, Brenner MB, Bonmassar E, Graziani G. Giuliani A, et al. Among authors: tentori l. Pharmacol Res. 1997 Feb;35(2):135-40. doi: 10.1006/phrs.1997.0130. Pharmacol Res. 1997. PMID: 9175583
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells.
Tentori L, Portarena I, Bonmassar E, Graziani G. Tentori L, et al. Cell Death Differ. 2001 May;8(5):457-69. doi: 10.1038/sj.cdd.4400832. Cell Death Differ. 2001. PMID: 11423906
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.
Tentori L, Portarena I, Graziani G. Tentori L, et al. Pharmacol Res. 2002 Feb;45(2):73-85. doi: 10.1006/phrs.2001.0935. Pharmacol Res. 2002. PMID: 11846617 Review.
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site.
Tentori L, Leonetti C, Scarsella M, d'Amati G, Portarena I, Zupi G, Bonmassar E, Graziani G. Tentori L, et al. Blood. 2002 Mar 15;99(6):2241-4. doi: 10.1182/blood.v99.6.2241. Blood. 2002. PMID: 11877304
Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes.
Tentori L, Portarena I, Vernole P, Gold B, Graziani G. Tentori L, et al. Cancer Chemother Pharmacol. 2002 Mar;49(3):217-24. doi: 10.1007/s00280-001-0409-z. Epub 2002 Jan 22. Cancer Chemother Pharmacol. 2002. PMID: 11935214
231 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page